Alexamorelin

Published · Researched 2026-09-21

Research date: 2026-09-20

Overview

Alexamorelin is a GHRP-class (growth hormone–releasing peptide) ghrelin-receptor agonist named by WADA in its prohibited list, with essentially no commercial or clinical footprint of its own. No approved finished product, no brand, and no developer program could be verified — it exists in public records almost entirely as a line item in doping regulations alongside GHRP-1 through GHRP-6. As of 2026-09-20 it is best described as a legacy research-chemical name in the ghrelin-mimetic family, with no therapeutic development program.

Social standing

Platform pulse: near-zero. Across the ~170 social posts gathered for this track (Threads / FB Groups / Instagram / FB Pages), Alexamorelin does not appear in a single post summary — no testimonials, no supplier promos, no educational reels. The only community-adjacent signal is regulatory:

  • WADA's Prohibited List (S2.2.4) names Alexamorelin explicitly among the GH-releasing peptides, alongside GHRP-1, GHRP-2 (pralmorelin), GHRP-3, GHRP-4, GHRP-5, and GHRP-6 (examorelin/hexarelin).
  • A 2016 NutraIngredients report on WADA/Interpol cooperation lists alexamorelin among the peptides on the prohibited list, in the context of supplement contamination risk.

Group consensus: None exists — there is no user community discussing this compound. Anyone buying "alexamorelin" from a research-chem catalog is likely buying a labeled GHRP-family vial with no verified usage base to calibrate against.

Main praise: none documented. Main complaints: none documented.

Social validation

Tier 3 — regulatory mention only; no community usage signal.

Source What it proves
https://www.drugs.com/wada/s2-peptide-hormones-growth-factors-and-related-substances.html WADA S2.2.4 lists alexamorelin among prohibited GHRPs (verified 2026-09-20)
https://WWW.NUTRAINGREDIENTS.COM/Article/2016/10/04/WADA-Interpol-unite-to-fight-doping-protein-peptides-included/ Alexamorelin named in WADA doping context since at least 2016

No forum, group, or creator content validates practical use, dosing, or outcomes.

Key specs table

Spec Value
Class Growth hormone–releasing peptide (GHRP), ghrelin-receptor (GHS-R1a) agonist family
Mechanism GHSR-1a agonism → pituitary GH release (per GHRP class placement in WADA listing)
Half-life UNVERIFIED — no published PK found
Route Subcutaneous injection (assumed from class; UNVERIFIED)
Community-reported dosing None — no community dosing patterns exist
MW / CAS UNVERIFIED — no verified chemical data located

Pricing

  • No verified price. No research-chem listings for "alexamorelin" were price-checked in this batch; no listings observed on FB Marketplace 2026-09-20.
  • Street/research-chem pricing: UNVERIFIED — do not quote a number from catalogs that may be selling mislabeled product.

What's included / what's needed

Factual contents only: if encountered at all, Alexamorelin appears in the grey market as lyophilized powder in vials labeled "for research use only" — identical in format to other research peptides. No branded kit, diluent, or documentation of provenance is associated with it. (No instructions for use are provided here.)

Support reality

No support of any kind. No pharmaceutical owner, no clinician channel, no brand support program. Research-chem COA culture (third-party purity certificates) is the only quality signal available, and those documents are frequently forged or reused — treat any such COA with skepticism.

Regulatory & safety status

  • Regulatory: Not approved by FDA, EMA, or any national regulator located. Pure research-chemical status — "not for human use" by definition.
  • WADA: Prohibited at all times under S2.2.4 (GH-releasing peptides), explicitly named.
  • Safety signals: No published human safety data located. GHRP-class risks (hunger, cortisol/prolactin elevation, tachyphylaxis) apply by class association, but compound-specific safety is UNVERIFIED.

Community verdict

There is no community around Alexamorelin — it is a regulatory ghost, named only on doping lists. Its Tier 3 standing reflects the absence of any user base, clinical program, or verified product to evaluate, and anyone offered it should assume mislabeling risk is high.

Image log

  • 8 views: 0 present, 8 missing. Two image searches ("alexamorelin peptide vial", "alexamorelin research peptide bottle label") returned only mismatched products (sermorelin, SS-31, generic peptide blends) — no genuine Alexamorelin product photo exists in indexed search results as of 2026-09-20. Honestly missing: hero, side, rear, top, detail, inuse, scale, box.

Open questions / UNVERIFIED

  • Molecular weight and CAS number — unverifiable; no reliable chemical record located.
  • Half-life, route, and dosing — no published or community data; unverifiable.
  • Whether any "alexamorelin" sold online is the genuine compound — unverifiable; assume mislabeling risk.
  • Approved status in any jurisdiction — unverifiable; none found.

Not medical advice. This file is research documentation only; nothing here is a recommendation to use any compound.

Sources